Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Progress in Cubist/Bristol-Myers Squibb antiinfective collaboration

April 11, 1997

Fujisawa describes new oral cephem antibiotic

April 11, 1997

Aldara approved in U.S.

April 11, 1997

Antiviral dihydropyrans from Biota

April 11, 1997

Retrospective analysis confirms efficacy and safety of Amphotec in aspergillosis

April 10, 1997

beta-Lactamase inhibitors described by SynPhar

April 10, 1997

Additional phase I/II trial results for MEDI-493

April 10, 1997

Antimicrobial/antineoplastic antibiotic discovered by Ajinomoto

April 9, 1997

Hybridon receives clearance to initiate further GEM-132 trials

April 8, 1997

Antibacterial mupirocin sulfamates from SmithKline Beecham

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.